Skip to main content

Advertisement

Log in

Predictive value of naitfold capillaroscopy in patients with Raynaud’s phenomenon

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

The objective of this study was to evaluate the long-term follow-up of patients with Raynaud’s phenomenon (RP) and pathological nailfold capillaroscopy (NC) in order to analyse the predictive value of specific features of capillaroscopy for the development of a connective tissue disease (CTD). From 1992 to 2002, NC alone or combined with fluorescence videomicroscopy with sodium fluorescein (NaF) was performed in 1024 consecutive patients because of RP. We analysed the follow-up and pathological features of NC in all patients who had neither clinical nor serological signs of a CTD at the time of NC. Of 308 patients with neither serological findings nor clinical signs of CTD but with RP and pathological features in NC suspicious for CTD, follow-up data were available for 133 patients. An additional NaF test had been performed in 51 (38.4%) patients. After a mean follow-up of 6.5 years (range: 1–15 years), 109 patients had developed a CTD and 24 patients did not show any clinical signs or serological markers for a CTD after a mean follow-up of 8.5 years (range: 2–15 years). There were no differences in age, duration of RP or of follow-up in patients who developed a CTD compared to patients who did not. Significantly more giant capillaries (p=0.0001), avascular fields (p=0.02) and irregular architecture (p=0.0001) had been observed in patients who had developed a CTD during the follow-up of 6.5 years. The presence of giant capillaries, avascular fields and irregular architecture of nailfold capillaries is predictive for the development of a CTD in patients with RP.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Maricq HR, Carpentier PH, Weinrich MC, Keil JE, Franco A, Drouet P, Poncot OC, Maines MV (1993) Geographic variation in the prevalence of Raynaud’s phenomenon: Charleston, SC, USA, vs. Tarentaise, Savoie, France. J Rheumatol 20:70–76

    PubMed  CAS  Google Scholar 

  2. Kallenberg CG, Wouda AA, Hoet MH, van Venrooij WJ (1988) Development of connective tissue disease in patients presenting with Raynaud’s phenomenon: a six year follow up with emphasis on the predictive value of antinuclear antibodies as detected by immunoblotting. Ann Rheum Dis 47:634–641

    Article  PubMed  CAS  Google Scholar 

  3. Bennett R, Bluestone R, Holt PJ, Bywaters EG (1971) Survival in scleroderma. Ann Rheum Dis 30:581–588

    Article  Google Scholar 

  4. Tuffanelli DL, Winkelmann RK (1961) Systemic scleroderma, a clinical study of 727 cases. Arch Dermatol 84:359–371

    PubMed  CAS  Google Scholar 

  5. Fessel WJ (1974) Systemic lupus erythematosus in the community. Incidence, prevalence, outcome, and first symptoms; the high prevalence in black women. Arch Intern Med 134:1027–1035

    Article  PubMed  CAS  Google Scholar 

  6. Kallenberg CG, Wouda AA, The TH (1980) Systemic involvement and immunologic findings in patients presenting with Raynaud’s phenomenon. Am J Med 69:675–680

    Article  PubMed  CAS  Google Scholar 

  7. Wollersheim H, Thien T, Hoet MH, Van Venrooy WJ (1989) The diagnostic value of several immunological tests for antinuclear antibody in predicting the development of connective tissue disease in patients presenting with Raynaud’s phenomenon. Eur J Clin Invest 19:535–541

    Article  PubMed  CAS  Google Scholar 

  8. Weiner ES, Hildebrandt S, Senecal JL, Daniels L, Noell S, Joyal F, Roussin A, Earnshaw W, Rothfield NF (1991) Prognostic significance of anticentromere antibodies and anti-to-poisomerase I antibodies in Raynaud’s disease. A prospective study. Arthritis Rheum 34:68–77

    CAS  Google Scholar 

  9. Cutolo M, Sulli A, Pizzorni C, Accardo S (2000) Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 27:155–160

    PubMed  CAS  Google Scholar 

  10. Maricq HR, LeRoy EC, D’Angelo WA, Medsger TA Jr, Rodnan GP, Sharp GC, Wolfe JF (1980) Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders. Arthritis Rheum 23:183–189

    Article  PubMed  CAS  Google Scholar 

  11. Lee P, Sarkozi J, Bookman AA, Keystone EC, Armstrong SK (1986) Digital blood flow and nailfold capillary microscopy in Raynaud’s phenomenon. J Rheumatol 13:564–569

    PubMed  CAS  Google Scholar 

  12. Grassi W, Medico PD, Izzo F, Cervini C (2001) Microvascular involvement in systemic sclerosis: capillaroscopic findings. Semih Arthritis Rheum 30:397–402

    Article  CAS  Google Scholar 

  13. Zufferey P, Depairon M, Chamot AM, Monti M (1992) Prognostic significance of nailfold capillary microscopy in patients with Raynaud’s phenomenon and scleroderma-pattern abnormalities. A six-year follow-up study. Clin Rheumatol 11:536–541

    Article  PubMed  CAS  Google Scholar 

  14. Passiu G, Sebastiani GD, Galeazzi M, Tuveri MA, Nicosia PM, Boirivant R (1990) Prognostic factors in Raynaud’s phenomenon: usefulness of antinuclear antibodies and of periungual capillaroscopy. Medicina (Firenze) 10:405–407

    CAS  Google Scholar 

  15. Cutolo M, Grassi W, Matucci Cerinic M (2003) Raynaud’s phenomenon and the role of capillaroscopy. Arthritis Rheum 48:3023–3030

    Article  PubMed  Google Scholar 

  16. Brulisauer M, Bollinger A (1991) Measurement of different human microvascular dimensions by combination of videomi-croscopy with Na-fluorescein (NaF) and indocyanine green (ICG) in normals and patients with systemic sclerosis. Int J Microcirc Clin Exp 10:21–31

    PubMed  CAS  Google Scholar 

  17. Moneta G, Vollenweider U, Dubler B, Bollinger A (1986) Diagnostic value of capillaroscopy with and without fluorescent dyes to detect early connective tissue disease. Vasa 15:143–149

    PubMed  CAS  Google Scholar 

  18. Bollinger A, Fagrell B (1990) Clinical capillaroscopy. Hogrefe, Göttingen

    Google Scholar 

  19. Schmidt JA, Caspary L, von Bierbrauer A, Ehrly AM, Junger M, Jung F, Lawall H (1997) Standardization of nailfold capillary microscopy in routine diagnosis. Vasa 26:5–10

    PubMed  CAS  Google Scholar 

  20. Masi AT (1988) Classification of systemic sclerosis (scleroderma): relationship of cutaneous subgroups in early disease to outcome and serologic reactivity. J Rheumatol 15:894–898

    PubMed  CAS  Google Scholar 

  21. Alarcon-Segovia D, Cardiel MH (1989) Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients. J Rheumatol 16:328–334

    PubMed  CAS  Google Scholar 

  22. Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (second of two parts). N Engl J Med 292:403–407

    PubMed  CAS  Google Scholar 

  23. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS et al (2002) Classification criteria for Sjogren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61:554–558

    Article  PubMed  CAS  Google Scholar 

  24. Kenik JG, Maricq HR, Bole GG (1981) Blind evaluation of the diagnostic specificity of nailfold capillary microscopy in the connective tissue diseases. Arthritis Rheum 24:885–891

    Article  PubMed  CAS  Google Scholar 

  25. Maricq HR, LeRoy EC (1973) Patterns of finger capillary abnormalities in connective tissue disease by “wide-field” microscopy. Arthritis Rheum 16:619–628

    Article  PubMed  CAS  Google Scholar 

  26. Houtman PM, Kallenberg CG, Fidler V, Wouda AA (1986) Diagnostic significance of nailfold capillary patterns in patients with Raynaud’s phenomenon. An analysis of patterns discriminating patients with and without connective tissue disease. J Rheumatol 13:556–563

    PubMed  CAS  Google Scholar 

  27. Bollinger A, Jager K, Siegenthaler W (1986) Microangiopathy of progressive systemic sclerosis. Evaluation by dynamic fluorescence videomicroscopy. Arch Intern Med 146:1541–1545

    Article  PubMed  CAS  Google Scholar 

  28. Monticone G, Colonna L, Palermi G, Bono R, Puddu P (2000) Quantitative nailfold capillary microscopy findings in patients with acrocyanosis compared with patients having systemic sclerosis and control subjects. J Am Acad Dermatol 42:787–790

    Article  PubMed  CAS  Google Scholar 

  29. Jacobs MJ, Breslau PJ, Slaaf DW, Reneman RS, Lemmens JA (1987) Nomenclature of Raynaud’s phenomenon: a capillary microscopic and hemorheologic study. Surgery 101:136–145

    PubMed  CAS  Google Scholar 

  30. LeRoy EC, Medsger TA Jr (1992) Raynaud’s phenomenon: a proposal for classification. Clin Exp Rheumatol 10:485–488

    PubMed  CAS  Google Scholar 

  31. Redisch W, Messina EJ, Hughes G, McEwen C (1970) Capillaroscopic observations in rheumatic diseases. Ann Rheum Dis 29:244–253

    Article  PubMed  CAS  Google Scholar 

  32. Furtado RN, Pucinelli ML, Cristo VV, Andrade LE, Sato EI (2002) Scleroderma-like nailfold capillaroscopic abnormalities are associated with anti-Ul-RNP antibodies and Raynaud’s phenomenon in SLE patients. Lupus 11:35–41

    Article  PubMed  CAS  Google Scholar 

  33. Caspary L, Schmees C, Schoetensack I, Härtung K, Stannat S, Deicher H, Creutzig A, Alexander K (1991) Alterations of the nailfold capillary morphology associated with Raynaud phenomenon in patients with systemic lupus erythematosus. J Rheumatol 18:559–566

    PubMed  CAS  Google Scholar 

  34. Bongard O, Bounameaux H, Miescher PA, De Moerloose P (1995) Association of anticardiolipin antibodies and abnormal nailfold capillaroscopy in patients with systemic lupus erythematosus. Lupus 4:142–144

    Article  PubMed  CAS  Google Scholar 

  35. Cutolo M, Pizzorni C, Tuccio M, Burroni A, Craviotto C, Basso M, Seriólo B, Sulli A (2004) Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis. Rheumatology (Oxford) 43:719–726

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Beatrice R. Amann-Vesti.

Additional information

Published online: 11 June 2005

Rights and permissions

Reprints and permissions

About this article

Cite this article

Meli, M., Gitzelmann, G., Koppensteiner, R. et al. Predictive value of naitfold capillaroscopy in patients with Raynaud’s phenomenon. Clin Rheumatol 25, 153–158 (2006). https://doi.org/10.1007/s10067-005-1146-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-005-1146-1

Keywords

Navigation